CFI-400437

Modify Date: 2025-08-26 18:43:02

CFI-400437 Structure
CFI-400437 structure
Common Name CFI-400437
CAS Number 1169211-37-3 Molecular Weight 492.57
Density N/A Boiling Point N/A
Molecular Formula C29H28N6O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of CFI-400437


CFI-400437 is an indolinone-derived, ATP-competitive kinase inhibitor with high selectivity for PLK4 (IC50 of 0.6 nM)[1].

 Names

Name CFI-400437

 CFI-400437 Biological Activity

Description CFI-400437 is an indolinone-derived, ATP-competitive kinase inhibitor with high selectivity for PLK4 (IC50 of 0.6 nM)[1].
Related Catalog
In Vitro CFI-400437 is a potent inhibitor of MCF-7, MDA-MB-468 and MDA-MB231 cell growth[1]. CFI-400437 inhibits Aurora A, Aurora B, KDR and FLT-3 with IC50s of 0.37, 0.21, 0.48, and 0.18 µM, respectively, i.e. two orders of magnitude higher than its IC50 of 0.6 nM against PLK4[1]. CFI-400437 inhibits both AURKB and AURKC at concentrations <15 nM[2].
In Vivo CFI-400437 (25 mg/kg, ip, once daily for 21 d) exhibits antitumor activity against MDA-MB-468 breast cancer mouse xenograft model[1].
References

[1]. Radoslaw Laufer, et al. The discovery of PLK4 inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as novel antiproliferative agents. J Med Chem. 2013 Aug 8;56(15):6069-87.

[2]. Amreena Suri, et al. Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer. Int J Mol Sci. 2019 Apr 29;20(9):2112.

 Chemical & Physical Properties

Molecular Formula C29H28N6O2
Molecular Weight 492.57
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.